Kura Oncology KURA Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's total liabilities & equity?
- Kura Oncology (KURA) reported total liabilities & equity of $652.55M in Q1 2026.
- How has Kura Oncology's total liabilities & equity changed year-over-year?
- Kura Oncology's total liabilities & equity decreased by 12.3% year-over-year, from $743.76M to $652.55M.
- What is the long-term trend for Kura Oncology's total liabilities & equity?
- Over 5 years (2020 to 2025), Kura Oncology's total liabilities & equity has grown at a 2.7% compound annual growth rate (CAGR), from $647.21M to $738.36M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.